Yes: Tam has 3 rolls-1)w/invasive cancer, it's systemic therapy like chemo 2)in breast conservation (dcis or inv) it reduces the risk of local recur above and beyond surgery & XRT 3)it reduces the chance do a second/new er+ breast cancer elsewhere in the same or opposite breast by 40-50%.
Answered 10/3/2016
5.8k views
Yes, for ER+ DCIS: The addition of tamoxifen to surgery and radiation therapy for dcis significantly reduced the risk of invasive cancer on the same beast by 40 % and risk for in situ breast cancer on the other breast by 60 percent.
Answered 10/13/2013
5.8k views
11 doctors weighed in across 3 answers
7 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question